Cancer Drugs and United States Tariffs

Cancer Journal (United States) · Published 2025-09-01 · DOI 10.1097/ppo.0000000000000785

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1097/ppo.0000000000000785

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Harnessing Radiation Biology to Increase Cancer Cure Rates · Cancer Journal (United States) · 2025 · Same journal
• Alternative Radiotherapy Delivery Approaches to Modulate Radiation Response · Cancer Journal (United States) · 2025 · Same journal
• Older Patients With Hodgkin Lymphoma: A Contemporary Review · Cancer Journal (United States) · 2026 · Same journal
• Management of Classic Hodgkin Lymphoma in Special Clinical Situations · Cancer Journal (United States) · 2026 · Same journal
• Role of Immunotherapy and Targeted Agents to Treat Brain Metastases · Cancer Journal (United States) · 2026 · Same journal
• Advanced Imaging Techniques for the Detection and Follow-up of Brain Metastases · Cancer Journal (United States) · 2026 · Same journal
• Key Drivers and Mitigation Strategies of Oncology Drug Shortages 2023 to 2025 · Cancer Journal (United States) · 2025 · Same journal
• Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma · Cancer Journal (United States) · 2026 · Same journal
• Introduction to a Supplement From the Cancer Journal: The Journal of Principles and Practice of Oncology · Cancer Journal (United States) · 2025 · Same journal
• Integrating AI into the Clinical Workflows Across the Cancer Care Continuum: Opportunities and Challenges · Cancer Journal (United States) · 2025 · Same journal